دورية أكاديمية
Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs?
| العنوان: | Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs? |
|---|---|
| المؤلفون: | Wesevich, Austin, Ratain, Mark J. |
| المصدر: | JAMA Oncology ; volume 9, issue 11, page 1489 ; ISSN 2374-2437 |
| بيانات النشر: | American Medical Association (AMA) |
| سنة النشر: | 2023 |
| الوصف: | This Viewpoint discusses the US Food and Drug Administration’s Project Optimus, which focuses on new oncology drug dose optimization and examines concerns about the accelerated postmarketing approval of adjusted dosing of oncologic drugs. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1001/jamaoncol.2023.3292 |
| الإتاحة: | https://doi.org/10.1001/jamaoncol.2023.3292Test https://jamanetwork.com/journals/jamaoncology/articlepdf/2809036/jamaoncology_wesevich_2023_vp_230012_1699901559.84546.pdfTest |
| رقم الانضمام: | edsbas.D4062A58 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1001/jamaoncol.2023.3292 |
|---|